Calliditas Therapeutics AB (publ) (CALT) Short Interest Ratio & Short Volume → A lot of people are making this costly mistake (From WealthPress) (Ad) Free CALT Stock Alerts $21.01 -0.48 (-2.23%) (As of 11:22 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Calliditas Therapeutics AB (publ) Short Interest DataCurrent Short Volume7,300 sharesPrevious Short Volume6,300 sharesChange Vs. Previous Month+15.87%Dollar Volume Sold Short$163,958.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 15, 2024Outstanding Shares29,790,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume363 sharesAverage Trading Volume8,299 sharesToday's Volume Vs. Average4% Short Selling Calliditas Therapeutics AB (publ) ? Sign up to receive the latest short interest report for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCALT Short Interest Over TimeCALT Days to Cover Over TimeCALT Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Calliditas Therapeutics AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20247,300 shares $163,958.00 +15.9%N/A0.5 $22.46 2/29/20246,300 shares $134,312.85 +37.0%N/A0.4 $21.32 2/15/20244,600 shares $94,668.00 -20.7%N/A0.3 $20.58 1/31/20245,800 shares $132,588.00 No ChangeN/A0.4 $22.86 1/15/20245,800 shares $145,000.00 -43.1%N/A0.4 $25.00 12/31/202310,200 shares $262,588.80 +20.0%N/A0.6 $25.74 Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 12/15/20238,500 shares $187,765.00 -29.2%N/A0.6 $22.09 11/30/202312,000 shares $208,200.00 +26.3%N/A1.1 $17.35 11/15/20239,500 shares $161,215.00 +93.9%N/A0.9 $16.97 10/31/20234,900 shares $79,870.00 +63.3%N/A0.5 $16.30 10/15/20233,000 shares $52,050.00 -21.1%N/A0.3 $17.35 9/30/20233,800 shares $69,388.00 +40.7%N/A0.4 $18.26 9/15/20232,700 shares $43,104.42 -34.2%N/A0.3 $15.96 8/31/20234,100 shares $72,652.00 -48.1%N/A0.6 $17.72 8/15/20237,900 shares $152,707.00 +315.8%N/A1.1 $19.33 7/31/20231,900 shares $37,050.00 -24.0%N/A0.3 $19.50 7/15/20232,500 shares $40,125.00 +4.2%N/A0.4 $16.05 6/30/20232,400 shares $37,680.00 -51.0%N/A0.4 $15.70 6/15/20234,900 shares $89,363.75 -41.7%N/A0.8 $18.24 5/31/20238,400 shares $143,304.00 +47.4%N/A0.8 $17.06 5/15/20235,700 shares $145,350.00 +128.0%N/A0.5 $25.50 4/30/20232,500 shares $58,350.00 -77.3%N/A0.2 $23.34 4/15/202311,000 shares $272,250.00 -16.0%N/A0.8 $24.75 3/31/202313,100 shares $314,007.00 -42.3%N/A0.9 $23.97 3/15/202322,700 shares $572,948.00 +58.7%N/A1.6 $25.24 2/28/202314,300 shares $264,693.00 +346.9%N/A1.4 $18.51 2/15/20233,200 shares $57,472.00 +10.3%N/A0.3 $17.96 1/31/20232,900 shares $55,680.00 -52.5%N/A0.3 $19.20 1/15/20236,100 shares $120,780.00 -38.4%N/A0.6 $19.80 12/30/20229,900 shares $168,300.00 +67.8%N/A0.9 $17.00 12/15/20225,900 shares $115,616.40 -38.5%N/A0.5 $19.60 11/30/20229,600 shares $174,432.00 +37.1%N/A0.8 $18.17 11/15/20227,000 shares $115,500.00 +25.0%N/A0.7 $16.50 10/31/20225,600 shares $83,440.00 +60.0%N/A0.6 $14.90 10/15/20223,500 shares $54,600.00 -59.3%N/A0.4 $15.60 9/30/20228,600 shares $130,428.46 +230.8%N/A1.4 $15.17 9/15/20222,600 shares $41,106.00 -27.8%N/A0.5 $15.81 8/31/20223,600 shares $59,400.00 -49.3%N/A0.8 $16.50 8/15/20227,100 shares $153,005.00 +4.4%N/A1.4 $21.55 7/31/20226,800 shares $126,820.00 -9.3%N/A1 $18.65Crypto Market Preps For Trillions Worth of Inflows! (Ad)Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event CALT Short Interest - Frequently Asked Questions What is Calliditas Therapeutics AB (publ)'s current short interest? Short interest is the volume of Calliditas Therapeutics AB (publ) shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 7,300 shares of CALT short. Learn More on Calliditas Therapeutics AB (publ)'s current short interest. Which institutional investors are shorting Calliditas Therapeutics AB (publ)? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Calliditas Therapeutics AB (publ): Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Calliditas Therapeutics AB (publ)'s short interest increasing or decreasing? Calliditas Therapeutics AB (publ) saw a increase in short interest in March. As of March 15th, there was short interest totaling 7,300 shares, an increase of 15.9% from the previous total of 6,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Calliditas Therapeutics AB (publ)'s short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Calliditas Therapeutics AB (publ): Neurogene Inc. (3.42%), Nuvation Bio Inc. (1.97%), Mineralys Therapeutics, Inc. (5.75%), Silence Therapeutics plc (0.31%), Acelyrin, Inc. (13.95%), Olema Pharmaceuticals, Inc. (9.05%), Phathom Pharmaceuticals, Inc. (40.11%), CureVac (5.31%), Cogent Biosciences, Inc. (9.27%), Nurix Therapeutics, Inc. (13.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Calliditas Therapeutics AB (publ) stock? Short selling CALT is an investing strategy that aims to generate trading profit from Calliditas Therapeutics AB (publ) as its price is falling. CALT shares are trading down $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Calliditas Therapeutics AB (publ)? A short squeeze for Calliditas Therapeutics AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CALT, which in turn drives the price of the stock up even further. How often is Calliditas Therapeutics AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CALT, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NGNE Short Squeeze NUVB Short Squeeze MLYS Short Squeeze SLN Short Squeeze SLRN Short Squeeze OLMA Short Squeeze PHAT Short Squeeze CVAC Short Squeeze COGT Short Squeeze NRIX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CALT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research